(Q36059488)

11 August 2017

1 reference

title

Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma (English)

1 reference

11 August 2017

Vahakn B Shahinian

1

1 reference

11 August 2017

Yong-fang Kuo

2

1 reference

11 August 2017

Jean L Freeman

3

1 reference

11 August 2017

Eduardo Orihuela

4

1 reference

11 August 2017

James S Goodwin

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

103

1 reference

11 August 2017

issue

8

1 reference

11 August 2017

page(s)

1615-1624

1 reference

Estimating treatment benefits for the elderly: the effect of competing risks

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

21 January 2018

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

A structured debate: immediate versus deferred androgen suppression in prostate cancer-evidence for deferred treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Comparing treatments for localized prostate cancer--persisting uncertainty

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Critical evaluation of hormonal therapy for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Side effects of androgen deprivation therapy: monitoring and minimizing toxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

National practice patterns and time trends in androgen ablation for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Development of a comorbidity index using physician claims data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Hormonal therapy for prostate cancer: primum non nocere

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Risk of fracture after androgen deprivation for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Androgen deprivation therapy for asymptomatic advanced prostate cancer in the prostate specific antigen era: a national survey of urologist beliefs and practices

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Factors Associated With Initial Therapy for Clinically Localized Prostate Cancer: Prostate Cancer Outcomes Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Physicians' reactions to uncertainty in patient care. A new measure and new insights

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Practice trends in the diagnosis and management of prostate cancer in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20955

7 January 2021

Identifiers

DOI

10.1002/CNCR.20955

1 reference

release_5qfyrucx5fcrpb2ggmmk6oudju

11 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5qfyrucx5fcrpb2ggmmk6oudju

24 November 2022

mapped directly with Wikidata item

1 reference